International consensus on use of continuous glucose monitoring

Danne, Thomas, Nimri, Revital, Battelino, Tadej, Bergenstal, Richard M., Close, Kelly L., DeVries, J. Hans, Garg, Satish, Heinemann, Lutz +26 more·2017·Diabetes Care

Cited by (1,002)

Items 101–200 of 1,002

  1. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
    Ajjan, Ramzi A., Battelino, Tadej, Cos, Xavier, Del Prato, Stefano, Philips, Jean-Christophe, Meyer, Laurent, Seufert, Jochen, Seidu, Samuel · 2024 · Nature Reviews Endocrinology
  2. The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial
    Norbert Hermanns, Dominic Ehrmann, M Schipfer, Jens Kröger, Thomas Haak, Bernhard Kulzer · 2019 · Diabetes Research and Clinical Practice
  3. High residual C-peptide likely contributes to glycemic control in type 1 diabetes
    Michael Roehrhoff Rickels, Carmella Evans‐Molina, Henry T. Bahnson, Alyssa Ylescupidez, Kristen J. Nadeau, Wei Hao, Mark Allen Clements, Jennifer L. Sherr, Richard E. Pratley, Tamara S. Hannon et al. · 2020 · Journal of Clinical Investigation
  4. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin
    Fernando Gómez Peralta, Pratik Choudhary, Emmanuel Cosson, Concetta Irace, Birgit M. Rami-Merhar, Alexander Seibold · 2022 · Diabetes Obesity and Metabolism
  5. Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus
    Anass El Malahi, Michiel Van Elsen, Sara Charleer, Eveline Lia Dirinck, Kristien J. Ledeganck, Bart Keymeulen, Laurent Crenier, Régis Pierre Radermecker, Youri Taes, Chris Vercammen et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
  6. Glycemic Variability: Risk Factors, Assessment, and Control
    Boris P. Kovatchev · 2019 · Journal of Diabetes Science and Technology
  7. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic
    B. Predieri, F. Leo, Francesco Candia, L. Lucaccioni, S. Madeo, M. Pugliese, Valentina Vivaccia, P. Bruzzi, L. Iughetti · 2020 · Frontiers in Endocrinology
  8. Interpreting blood GLUcose data with R package iglu
    Steven Broll, J. Urbanek, David Buchanan, Elizabeth Chun, J. Muschelli, N. Punjabi, Irina Gaynanova · 2020 · bioRxiv
  9. The application of simple metrics in the assessment of glycaemic variability
    Louis Monnier, C Colette, David R. Owens · 2018 · Diabetes & Metabolism
  10. Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice
    Mary Lynn Johnson, Thomas W. Martens, Amy B. Criego, Anders L. Carlson, Gregg D. Simonson, Richard M. Bergenstal · 2019 · Diabetes Technology & Therapeutics
  11. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
    Jackson, Melanie A., Ahmann, Andrew, Shah, Viral N. · 2021 · Diabetes Technology & Therapeutics
  12. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
    Rishi Raj, Rahul Mishra, Nivedita Jha, Vivek R. Joshi, Ricardo Rafael Correa, Philip A. Kern · 2022 · BMJ Open Diabetes Research & Care
  13. Is an artificial pancreas (closed‐loop system) for Type 1 diabetes effective?
    Charlotte K. Boughton, Roman Hovorka · 2018 · Diabetic Medicine
  14. Enhancing self-management in type 1 diabetes with wearables and deep learning
    Taiyu Zhu, Chukwuma N. Uduku, Kezhi Li, Pau Herrero, Nick S. Oliver, Pantelis Georgiou · 2022 · npj Digital Medicine
  15. HbA1c: More than just a number
    Mawson Wang, Tien-Ming Hng · 2021 · Australian Journal of General Practice
  16. Update on biomarkers of glycemic control
    Krhač, Maja, Lovrenčić, Marijana Vučić · 2019 · World Journal of Diabetes
  17. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial
    Klemen Dovč, Claudia Anita Piona, Gül Yeşiltepe Mutlu, Nataša Bratina, Barbara Jenko Bizjan, Dušanka Lepej, Revital Nimri, Eran Atlas, Ido Muller, Olga Kordonouri et al. · 2019 · Diabetes Care
  18. HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis
    Jordan E. Perlman, T. Gooley, B. Mcnulty, Jedidiah Meyers, I. Hirsch · 2020 · Diabetes Technology & Therapeutics
  19. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
    Rayhan Lal, Laya Ekhlaspour, Korey K. Hood, Bruce A. Buckingham · 2019 · Endocrine Reviews
  20. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain
    Fernando Gómez Peralta, Timothy C. Dunn, Katherine Landuyt, Yongjin Xu, Juan Francisco Merino-Torres · 2020 · BMJ Open Diabetes Research & Care
  21. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
    Giovanni Musso, Roberto Gambino, Maurizio Cassader, Elena Paschetta · 2019 · BMJ
  22. Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross‐over trial
    Shaun A. Mason, Bodil Rasmussen, Luc J. C. van Loon, Jo Salmon, Glenn David Wadley · 2018 · Diabetes Obesity and Metabolism
  23. CGMap: Characterizing continuous glucose monitor data in thousands of non-diabetic individuals
    Ayya Keshet, Smadar Shilo, Anastasia Godneva, Yeela Talmor‐Barkan, Yaron Aviv, Eran Segal, Hagai Rossman · 2023 · Cell Metabolism
  24. Technology in the management of type 2 diabetes: Present status and future prospects
    AIDEEN B. DALY, Roman Hovorka · 2021 · Diabetes Obesity and Metabolism
  25. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
    Riddle, Matthew C, Cefalu, William T, Evans, Philip H, Gerstein, Hertzel C, Nauck, Michael A, Oh, William K, Rothberg, Amy E, le Roux, Carel W, Rubino, Francesco, Schauer, Philip et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  26. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
    Andreas Neu, Jutta Bürger-Büsing, Thomas Danne, Axel Dost, Martin Holder, Reinhard Walter Holl, PM Holterhus, T Kapellen, Beate Karges, Olga Kordonouri et al. · 2016 · Diabetologie und Stoffwechsel
  27. Glucose management for exercise using continuous glucose monitoring ( CGM ) and intermittently scanned CGM ( isCGM ) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes ( EASD ) and of the International Society for Pediatric and Adolescent Diabetes ( ISPAD ) endorsed by JDRF and supported by the American Diabetes Association ( ADA )
    Othmar Moser, Michael Charles Riddell, Max Lennart Eckstein, Peter Adolfsson, RÉMI P.R. RABASA-LHORET, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nick S. Oliver, Dessi P. Zaharieva et al. · 2020 · Pediatric Diabetes
  28. Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes
    Norbert Hermanns, Dominic Ehrmann, Amit Shapira, Bernhard Kulzer, ANDREAS J. SCHMITT, Lori M. Laffel · 2022 · Diabetologia
  29. Diabetes in Childhood and Adolescence
    Ralph Ziegler, Andreas Neu · 2018 · Deutsches Ärzteblatt international
  30. Continuous Glucose Monitoring Metrics and Birth Weight: Informing Management of Type 1 Diabetes Throughout Pregnancy
    ELEANOR M. SCOTT, Helen R. Murphy, Karl Heby Kristensen, Denice S. Feig, Karin Kjölhede, Linda Englund‐Ögge, Kerstin E. Berntorp, Graham R. Law · 2022 · Diabetes Care
  31. Use and accuracy of inpatient CGM during the COVID-19 pandemic: an observational study of general medicine and ICU patients
    Longo, Rebecca Rick, Elias, Heather, Khan, Mehvish, Seley, Jane Jefferie · 2022 · Journal of Diabetes Science and Technology
  32. Review of present method of glucose from human blood and body fluids assessment
    Klara Fiedorova, Martin Augustýnek, Jan Kubíček, Petr Kudrna, Daniele Bibbo · 2022 · Biosensors and Bioelectronics
  33. Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes
    Bergenstal, Richard M., Mullen, Deborah M., Strock, Ellie, Johnson, Mary L., Xi, Min X. · 2022 · Journal of Diabetes and its Complications
  34. Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ferreira, Rafael Oliva Morgado, Trevisan, Talita, Pasqualotto, Eric, Chavez, Matheus Pedrotti, Marques, Beatriz Friedrichsen, Lamounier, Rodrigo Nunes, van de Sande-Lee, Simone · 2024 · Diabetes Technology & Therapeutics
  35. Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics
    Beyond A1C Writing Group · 2018 · Diabetes Care
  36. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study
    Guido Di Dalmazi, Giulio Maltoni, Claudio Bongiorno, Lorenzo Tucci, Valeria Di Natale, Simona Moscatiello, Gilberto Laffi, Andrea Pession, Stefano Zucchini, Uberto Pagotto · 2020 · BMJ Open Diabetes Research & Care
  37. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes
    Scott, Eleanor M., Feig, Denice S., Murphy, Helen R., Law, Graham R., The CONCEPTT Collaborative Group, Murphy, Helen, Grisoni, Jeannie, Byrne, Carolyn, Neoh, Sandra, Davenport, Katy et al. · 2020 · Diabetes Care
  38. REV-ERB in GABAergic neurons controls diurnal hepatic insulin sensitivity
    Guolian Ding, Xin Li, Xinguo Hou, Wenjun Zhou, Yingyun Gong, Fuqiang Liu, Yanlin He, Jia Song, Jing Wang, Paul Basil et al. · 2021 · Nature
  39. Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Castellana, Marco, Parisi, Claudia, Di Molfetta, Sergio, Di Gioia, Ludovico, Natalicchio, Annalisa, Perrini, Sebastio, Cignarelli, Angelo, Laviola, Luigi, Giorgino, Francesco · 2020 · BMJ Open Diabetes Research & Care
  40. Noninvasive Glucose Measurement Using Machine Learning and Neural Network Methods and Correlation with Heart Rate Variability
    Marjan Gušev, Lidija Poposka, Gjoko Spasevski, Magdalena Kostoska, Bojana Koteska, Monika Simjanoska, Nevena Ackovska, Aleksandar Stojmenski, Jurij Franc Tasič, Janez K. Trontelj · 2020 · Journal of Sensors
  41. Chinese diabetes datasets for data-driven machine learning
    Qinpei Zhao, Jinhao Zhu, Xuan Shen, Chuwen Lin, Yinjia Zhang, Yuxiang Liang, Baige Cao, Jiangfeng Li, Xiang Liu, Weixiong Rao et al. · 2023 · Scientific Data
  42. Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment
    Meldgaard, Theresa, Olesen, Søren Schou, Farmer, Adam D., Krogh, Klaus, Wendel, Anne Astrid, Brock, Birgitte, Drewes, Asbjørn Mohr, Brock, Christina · 2018 · Journal of Diabetes Research
  43. Evolution of Diabetes Technology
    Klemen Dovč, Tadej Battelino · 2019 · Endocrinology and Metabolism Clinics of North America
  44. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy
    Julia Fuchs, Roman Hovorka · 2020 · Expert Review of Medical Devices
  45. Glycemic Variability and CNS Inflammation: Reviewing the Connection
    Charles Watt, ELIZABETH SANCHEZ RANGEL, Janice Jin Hwang · 2020 · Nutrients
  46. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: a pilot, multicentre, randomised controlled trial
    Ajjan, Ramzi A, Jackson, Neil, Thomson, Scott A · 2019 · Diabetes and Vascular Disease Research
  47. First Look at Control-IQ: A New-Generation Automated Insulin Delivery System
    Sue A. Brown, Dan Raghinaru, Emma G. Emory, Boris P. Kovatchev · 2018 · Diabetes Care
  48. cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data
    T. Vigers, Christine L. Chan, J. Snell-Bergeon, P. Bjornstad, P. Zeitler, Gregory P. Forlenza, L. Pyle · 2019 · PLoS ONE
  49. Effect of High Versus Low Carbohydrate Intake in the Morning on Glycemic Variability and Glycemic Control Measured by Continuous Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus—A Randomized Crossover Study
    Louise Munk Rasmussen, Maria Lund Christensen, Charlotte Wolff Poulsen, Charlotte Lock Rud, Alexander Sidelmann Christensen, Jens Rikardt Andersen, Ulla Kampmann, Per Ovesen · 2020 · Nutrients
  50. Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies
    Lin, Yu Kuei, Fisher, Simon J, Pop‐Busui, Rodica · 2020 · Journal of Diabetes Investigation
  51. Impaired Awareness of Hypoglycemia Continues to be a Risk Factor for Severe Hypoglycemia Despite the Use of Continuous Glucose Monitoring System in Type 1 Diabetes
    Yu Kuei Lin, Man Hung, Anu Rani Sharma, Owen T. M. Chan, Michael Walter Varner, Gitana Staskus, Simon J. Fisher · 2019 · Endocrine Practice
  52. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes
    Timothy C. Dunn, Ramzi Ajjan, Richard M. Bergenstal, Yongjin Xu · 2024 · Diabetes Technology & Therapeutics
  53. Long‐term real‐life glycaemic outcomes with a hybrid closed‐loop system compared with sensor‐augmented pump therapy in patients with type 1 diabetes
    Halis Kaan Aktürk, DOMINIQUE A. GIORDANO, Anagha Champakanath, SCOTT J. BRACKETT, Satish K. Garg, Janet K. Snell‐Bergeon · 2019 · Diabetes Obesity and Metabolism
  54. A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
    Kovatchev, Boris · 2019 · Trends in Endocrinology & Metabolism
  55. A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
    Elias K. Spanakis, Curtiss Bela Cook, Kristen M. Kulasa, Joseph Aloi, Lia Bally, Georgia M. Davis, Kathleen Marie Dungan, Rodolfo Javier Galindo, Carlos E. Mendez, Francisco J. Pasquel et al. · 2023 · Journal of Diabetes Science and Technology
  56. Laser-Induced Mesoporous Nickel Oxide as a Highly Sensitive Nonenzymatic Glucose Sensor
    Sotoudeh Sedaghat, Chad R. Piepenburg, Amin Zareei, Zhimin Qi, Samuel Peana, Haiyan Wang, Rahim Rahimi · 2020 · ACS Applied Nano Materials
  57. The Impact of a Recently Approved Automated Insulin Delivery System on Glycemic, Sleep, and Psychosocial Outcomes in Older Adults With Type 1 Diabetes: A Pilot Study
    Alessandro Bisio, Linda A Gonder-Frederick, Ryan K. McFadden, Daniel R. Cherñavvsky, Mary K. Voelmle, Michael Pajewski, Pearl L. Yu, Heather Bonner, Sue A. Brown · 2021 · Journal of Diabetes Science and Technology
  58. The second generation of The Avon Longitudinal Study of Parents and Children (ALSPAC-G2): a cohort profile
    D. Lawlor, M. Lewcock, Louise Rena-Jones, Claire Rollings, V. Yip, Daniel Smith, R. Pearson, Laura Johnson, L. Millard, Nashita Patel et al. · 2019 · Wellcome Open Research
  59. Management of Glucocorticoid-Induced Hyperglycemia
    Shah, Parag, Kalra, Sanjay, Yadav, Yogesh, Deka, Nilakshi, Lathia, Tejal, Jacob, Jubbin Jagan, Kota, Sunil Kumar, Bhattacharya, Saptarshi, Gadve, Sharvil S, Subramanium, KAV et al. · 2022 · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
  60. Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial
    Othmar Moser, Max Lennart Eckstein, Olivia Mary McCarthy, Rachel Deere, Jason P. Pitt, David M. Williams, Jennifer Hayes, Harald Sourij, Stephen Charles Bain, Richard M. Bracken · 2019 · Diabetes Obesity and Metabolism
  61. Superswelling Microneedle Arrays for Dermal Interstitial Fluid (Prote)Omics
    Elise Laszlo, Grégory De Crescenzo, Alfonso Nieto-Argüello, Xavier Banquy, Davide Brambilla · 2021 · Advanced Functional Materials
  62. Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes
    Qingyu Guo, Pu Zang, Shao-ying Xu, Wenjing Song, Zhen Zhang, Chunyan Liu, Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu et al. · 2020 · Journal of Diabetes Research
  63. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study
    Jonathan Petersson, Karin Åkesson, Frida Sundberg, Stefan Särnblad · 2019 · Pediatric Diabetes
  64. Offline reinforcement learning for safer blood glucose control in people with type 1 diabetes
    Harry Emerson, Matthew Guy, Ryan McConville · 2023 · Journal of Biomedical Informatics
  65. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study
    Jolien De Meulemeester, Sara Charleer, Margaretha M. Visser, Christophe E.M. De Block, Chantal Mathieu, Pieter Gillard · 2024 · Diabetologia
  66. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
    Miller, Kellee M., Kanapka, Lauren G., Rickels, Michael R., Ahmann, Andrew J., Aleppo, Grazia, Ang, Lynn, Bhargava, Anuj, Bode, Bruce W., Carlson, Anders, Chaytor, Naomi S. et al. · 2022 · Diabetes Technology & Therapeutics
  67. Insulin Pump Therapy
    Revital Nimri, Judith Nir, Moshe Phillip · 2019 · American Journal of Therapeutics
  68. Evaluation of the FreeStyle® Libre Flash Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes
    Guy Massa, Inge Gys, Anniek Op’t Eyndt, Esmiralda Bevilacqua, Anne Wijnands, Peter E Declercq, Renate Zeevaert · 2018 · Hormone Research in Paediatrics
  69. Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump-treated type 1 diabetes
    Ranjan, Ajenthen G., Rosenlund, Signe V., Hansen, Tine W., Rossing, Peter, Andersen, Steen, Nørgaard, Kirsten · 2020 · Diabetes Care
  70. The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method
    Daniela Bruttomesso, Luigi Laviola, Angelo Avogaro, Enzo Bonora, Stefano Del Prato, Simona Frontoni, Emanuela Orsi, Ivana Rabbone, Giorgio Sesti, Francesco Purrello · 2019 · Nutrition Metabolism and Cardiovascular Diseases
  71. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study
    Viral N. Shah, Lauren G. Kanapka, Halis Kaan Aktürk, Sarit Polsky, Gregory P. Forlenza, Craig Kollman, Roy W. Beck, Janet K. Snell‐Bergeon · 2023 · Diabetes Technology & Therapeutics
  72. Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial
    Nanna Lind, Merete Bechmann Christensen, Dorte Lindqvist Hansen, Kirsten Nørgaard · 2024 · Diabetes Care
  73. Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT ‐2 study): 52‐week results from a randomized controlled trial
    Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, Eiichi Araki, Marcus Lind, Niki Arya, FREDRIK A. THOREN, Markus Florian Scheerer, Nayyar Iqbal, Paresh Dandona · 2020 · Diabetes Obesity and Metabolism
  74. TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes
    Fengwen Li, Yinan Zhang, Huizhi Li, Jingyi Lu, Lan Jiang, Robert Alan Vigersky, Jian Zhou, Congrong Wang, Yuqian Bao, Weiping Jia · 2020 · Diabetes Research and Clinical Practice
  75. The relationship between CGM-derived metrics, A1C, and risk of hypoglycemia in older adults with type 1 diabetes
    Toschi, Elena, Slyne, Christine, Sifre, Kayla, O’Donnell, Rachel, Greenberg, Jordan, Atakov-Castillo, Astrid, Carl, Sam, Munshi, Medha · 2020 · Diabetes Care
  76. PREVENT: A Randomized, Placebo-Controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia
    Craig, Colleen M, Lawler, Helen Margaret, Lee, Clare Jung Eun, Tan, Marilyn, Davis, Dawn Belt, Tong, Jenny, Glodowski, Michele, Rogowitz, Elisa, Karaman, Rowan, McLaughlin, Tracey L et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
  77. Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia
    Anderson, Stacey M., Buckingham, Bruce A., Breton, Marc D., Robic, Jessica L., Barnett, Charlotte L., Wakeman, Christian A., Oliveri, Mary C., Brown, Sue A., Ly, Trang T., Clinton, Paula K. et al. · 2019 · Diabetes Technology & Therapeutics
  78. Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis
    JOHAN H. JENDLE, Åsa Ericsson, Jens Gundgaard, Jonas Bech Møller, William J. Valentine, Barnaby Hunt · 2020 · Diabetes Therapy
  79. Impact of CGM on the management of hypoglycemia problems: overview and secondary analysis of the HypoDE study
    Hermanns, Norbert, Heinemann, Lutz, Freckmann, Guido, Waldenmaier, Delia, Ehrmann, Dominic · 2019 · Journal of Diabetes Science and Technology
  80. Postprandial Hypoglycaemia after Roux-en-Y Gastric Bypass and the Effects of Acarbose, Sitagliptin, Verapamil, Liraglutide and Pasireotide
    Øhrstrøm, Caroline Christfort, Worm, Dorte, Højager, Anna, Andersen, Ditte, Holst, Jens Juul, Kielgast, Urd Lynge, Hansen, Dorte Lindqvist · 2019 · Diabetes, Obesity and Metabolism
  81. Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life
    Eshen Ang, Zong Xuan Lee, Sacha L. Moore, Melanie Nana · 2020 · Journal of Diabetes and its Complications
  82. Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes
    Ze-Kai Wu, Si-Hui Luo, Xue-Ying Zheng, Y. Bi, Wen Xu, Jin-Hua Yan, Dai-Zhi Yang, J. Weng · 2020 · Therapeutic Advances in Endocrinology and Metabolism
  83. Time restricted eating for the prevention of type 2 diabetes
    Sofia Cienfuegos, Mara McStay, Kelsey Gabel, Krista A Varady · 2021 · The Journal of Physiology
  84. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology
    Pilar Isabel Beato-Víbora, Fabiola Gallego-Gamero, Lucía Lázaro-Martín, María del Mar Romero-Pérez, Francisco Javier Arroyo-Díez · 2019 · Diabetes Technology & Therapeutics
  85. Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
    Tadej Battelino, Richard M Bergenstal, Angel Rodríguez, Laura Fernández Landó, Ross Bray, Zhentao Tong, Katelyn Brown · 2022 · The Lancet Diabetes & Endocrinology
  86. Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease
    Tomasz Klupa, Leszek Czupryniak, Grzegorz Jan Dzida, Piotr Fichna, Przemysława A. Jarosz-Chobot, Janusz Gumprecht, Małgorzata Myśliwiec, Agnieszka Szadkowska, Dorota Agata Bomba-Opon, Krzysztof Czajkowski et al. · 2023 · Diabetes Therapy
  87. Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
    Thomas Danne, Bertrand Cariou, John B. Buse, Satish K. Garg, Julio Rosenstock, Phillip Lee Banks, Jake A. Kushner, Darren K. McGuire, Anne L. Peters, Sangeeta Sawhney et al. · 2019 · Diabetes Care
  88. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown
    Avivit Brener, Kineret Mazor‐Aronovitch, Marianna Rachmiel, Noah Levek, Galia Barash, Orit Pinhas‐Hamiel, Yael Lebenthal, Zohar Landau · 2020 · Acta Diabetologica
  89. Time in range centered diabetes care
    Klemen Dovč, Tadej Battelino · 2021 · Clinical Pediatric Endocrinology
  90. Glucose variability: a new risk factor for cardiovascular disease
    Martina Belli, Alfonso Bellia, Domenico Sergi, Lucy Barone, Davide Lauro, Francesco Barillà · 2023 · Acta Diabetologica
  91. Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation
    Grazia Aleppo, Kimberly M Webb · 2018 · Journal of Diabetes Science and Technology
  92. Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy
    Junpeng Yang, Xueli Yang, Dongni Zhao, Xiaobing Wang, Wei Wei, Huijuan Yuan · 2020 · Journal of Diabetes Investigation
  93. Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach
    Peter Adolfsson, Christopher G. Parkin, Andreas Thomas, Lars Krinelke · 2018 · touchREVIEWS in Endocrinology
  94. Glycaemic variability: The under‐recognized therapeutic target in type 1 diabetes care
    Emma G. Wilmot, Pratik Choudhary, Lalantha Leelarathna, Mike Baxter · 2019 · Diabetes Obesity and Metabolism
  95. The Use of Continuous Glucose Monitors in Sport: Possible Applications and Considerations
    Amy-Lee M. Bowler, Jamie Whitfield, Lachlan Marshall, Vernon G. Coffey, Louise M. Burke, Gregory R. Cox · 2022 · International Journal of Sport Nutrition and Exercise Metabolism
  96. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry
    Viral N. Shah, Mengdi Wu, Sarit Polsky, Janet K. Snell‐Bergeon, Jennifer L. Sherr, Eda Cengiz, Linda Anne DiMeglio, Rodica Pop‐Busui, Kara Mizokami‐Stout, Nicole C. Foster et al. · 2018 · Journal of Diabetes and its Complications
  97. Associations between HbA1c and continuous glucose monitoring‐derived glycaemic variables
    Irl B. Hirsch, John B. Welsh, Peter M. Calhoun, Sarah Puhr, Tomas C. Walker, David A. Price · 2019 · Diabetic Medicine
  98. Standardization process of continuous glucose monitoring: Traceability and performance
    Freckmann, Guido, Nichols, James H., Hinzmann, Rolf, Klonoff, David C., Ju, Yi, Diem, Peter, Makris, Konstantinos, Slingerland, Robbert J. · 2021 · Clinica Chimica Acta
  99. Isocaloric-restricted Mediterranean Diet and Chinese Diets High or Low in Plants in Adults With Prediabetes
    Yaogan Luo, Jiqiu Wang, Liang Dan Sun, Weiqiong Gu, Geng Zong, Boyu Song, Chongrong Shen, Puchen Zhou, Yufei Chen, Yanpu Wu et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  100. Assessment of glucose variability in subjects with prediabetes
    Nevena Y. Chakarova, Rumyana B. Dimova, Greta G. Grozeva, Tsvetalina I. Tankova · 2019 · Diabetes Research and Clinical Practice